NDC 0006-3074 Zepatier
Elbasvir And Grazoprevir Tablet, Film Coated Oral - View Dosage, Usage, Ingredients, Routes, UNII
Product Information
- 0006 - Merck Sharp & Dohme Llc
- 0006-3074 - Zepatier
Product Characteristics
Product Packages
NDC Code 0006-3074-02
Package Description: 2 DOSE PACK in 1 CARTON / 14 TABLET, FILM COATED in 1 DOSE PACK (0006-3074-01)
Price per Unit: $634.23750 per EA
Product Details
What is NDC 0006-3074?
What are the uses for Zepatier?
What are Zepatier Active Ingredients?
Which are Zepatier UNII Codes?
The UNII codes for the active ingredients in this product are:
- ELBASVIR (UNII: 632L571YDK)
- ELBASVIR (UNII: 632L571YDK) (Active Moiety)
- GRAZOPREVIR ANHYDROUS (UNII: 8YE81R1X1J)
- GRAZOPREVIR ANHYDROUS (UNII: 8YE81R1X1J) (Active Moiety)
Which are Zepatier Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- COPOVIDONE K25-31 (UNII: D9C330MD8B)
- CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
- HYPROMELLOSE 2910 (3 MPA.S) (UNII: 0VUT3PMY82)
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- MANNITOL (UNII: 3OWL53L36A)
- MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
- SODIUM CHLORIDE (UNII: 451W47IQ8X)
- SODIUM LAURYL SULFATE (UNII: 368GB5141J)
- TOCOPHERSOLAN (UNII: O03S90U1F2)
- CARNAUBA WAX (UNII: R12CBM0EIZ)
- FERROSOFERRIC OXIDE (UNII: XM0M87F357)
- HYPROMELLOSE 2910 (15 MPA.S) (UNII: 36SFW2JZ0W)
- FERRIC OXIDE RED (UNII: 1K09F3G675)
- FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- TRIACETIN (UNII: XHX3C3X673)
What is the NDC to RxNorm Crosswalk for Zepatier?
- RxCUI: 1734636 - elbasvir 50 MG / grazoprevir 100 MG Oral Tablet
- RxCUI: 1734642 - Zepatier 50 MG / 100 MG Oral Tablet
- RxCUI: 1734642 - elbasvir 50 MG / grazoprevir 100 MG Oral Tablet [Zepatier]
- RxCUI: 1734642 - Zepatier (elbasvir 50 MG / grazoprevir 100 MG) Oral Tablet
Which are the Pharmacologic Classes for Zepatier?
- Breast Cancer Resistance Protein Inhibitors - [MoA] (Mechanism of Action)
- Breast Cancer Resistance Protein Inhibitors - [MoA] (Mechanism of Action)
- Cytochrome P450 3A Inhibitors - [MoA] (Mechanism of Action)
- HCV NS3/4A Protease Inhibitors - [MoA] (Mechanism of Action)
- Hepatitis C Virus NS3/4A Protease Inhibitor - [EPC] (Established Pharmacologic Class)
- Hepatitis C Virus NS5A Inhibitor - [EPC] (Established Pharmacologic Class)
* Please review the disclaimer below.
Patient Education
Elbasvir and Grazoprevir
The combination of elbasvir and grazoprevir is used alone or in combination with ribavirin (Copegus, Rebetol, Ribasphere, Virazole) to treat a certain type of chronic (long-term) hepatitis C infection (swelling of the liver caused by a virus) in adults and children 12 years of age or older. Elbasvir is in a class of antiviral medications called HCV NS5A inhibitors. It works by stopping the virus that causes hepatitis C from spreading inside the body. Grazoprevir is in a class of medications called protease inhibitors. It works by decreasing the amount of hepatitis C virus (HCV) in the body. It is not known if elbasvir and grazoprevir prevent the spread of hepatitis C to other people.
[Learn More]
* Please review the disclaimer below.
[1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
[2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
[3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
[4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".